Advertisement
UK markets close in 3 hours 25 minutes
  • FTSE 100

    8,232.29
    -15.50 (-0.19%)
     
  • FTSE 250

    20,341.03
    -22.40 (-0.11%)
     
  • AIM

    766.74
    -1.29 (-0.17%)
     
  • GBP/EUR

    1.1839
    +0.0002 (+0.01%)
     
  • GBP/USD

    1.2661
    -0.0026 (-0.20%)
     
  • Bitcoin GBP

    48,579.88
    +304.12 (+0.63%)
     
  • CMC Crypto 200

    1,273.57
    -10.21 (-0.80%)
     
  • S&P 500

    5,469.30
    +21.43 (+0.39%)
     
  • DOW

    39,112.16
    -299.05 (-0.76%)
     
  • CRUDE OIL

    81.27
    +0.44 (+0.54%)
     
  • GOLD FUTURES

    2,325.40
    -5.40 (-0.23%)
     
  • NIKKEI 225

    39,667.07
    +493.92 (+1.26%)
     
  • HANG SENG

    18,089.93
    +17.03 (+0.09%)
     
  • DAX

    18,143.66
    -33.96 (-0.19%)
     
  • CAC 40

    7,603.71
    -58.59 (-0.76%)
     

GameStop falls while Dave & Buster's and Blue Apron rise

GameStop falls while Dave & Buster's and Blue Apron rise

NEW YORK (AP) -- Stocks that moved substantially or traded heavily on Wednesday:

GameStop Corp., down 47 cents to $9.63

The video game retailer's first-quarter profit and revenue fell short of analysts' expectations and it gave investors a weak forecast.

Dave & Buster's Entertainment Inc., up $2.47 to $52.95

The restaurant and arcade chain's fourth-quarter profit and a key sales measure blew past Wall Street expectations.

Advanced Micro Devices Inc., up $2.27 to $29.02

The chipmaker and its rivals gained on media reports that orders for smartphone chips are higher so far this quarter.

Intel Corp., up $1.12 to $55.48

ADVERTISEMENT

The chipmaker named George Davis its new chief financial officer, after hiring him away from rival Qualcomm.

Blue Apron Holdings Inc., up 7 cents to $1.04

The meal-kit seller's CEO is resigning and will be replaced by a former Etsy Inc. executive.

Nektar Therapeutics Inc., up $1.59 to $35.29

The biotechnology company presented a series of positive early studies for potential cancer treatments.

Acuity Brands Inc., up $10.90 to $134.79

The lighting maker beat Wall Street's profit forecasts for the fiscal second quarter.

USANA Health Sciences Inc., down $2.90 to $81.25

The nutritional supplements company expects a drop in sales during the first quarter, citing a lack of promotional activity.